目次

Table of Contents

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Central Nervous System Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Central Nervous System Drugs

9. Central Nervous System Drugs Market Size And Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers Of The Market
9.2.2. Restraints On The Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers Of The Market
9.3.2. Restraints On The Market

10. Central Nervous System Drugs Market Regional Analysis
10.1. Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
10.2. Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
10.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

11. Central Nervous System Drugs Market Segmentation
11.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Pharmaceutical Drugs
Biologics
11.2. Global Central Nervous System Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Analgesics
Anti-Parkinson drugs
Anesthetics
Anti-Epileptics
Alzheimer
Diabetic Neuropathy
Other CNS drugs
11.3. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others
11.4. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Oral
Parenteral
Others
11.5. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Branded Drugs
Generic Drugs
11.6. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs

12. Central Nervous System Drugs Market Metrics
12.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
12.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Central Nervous System Drugs Market
13.1. Asia-Pacific Central Nervous System Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
13.3. Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
13.4. Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
13.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
13.6. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
13.7.1. China Central Nervous System Drugs Market
13.7.1.1. China Central Nervous System Drugs Market Overview
13.7.1.2. China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.1.3. China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.2. Australia Central Nervous System Drugs Market
13.7.2.1. Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.2.2. Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.3. Hong Kong Central Nervous System Drugs Market
13.7.3.1. Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.4. India Central Nervous System Drugs Market
13.7.4.1. India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.4.2. India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.5. Indonesia Central Nervous System Drugs Market
13.7.5.1. Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.5.2. Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.6. Japan Central Nervous System Drugs Market
13.7.6.1. Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.6.2. Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.7. Malaysia Central Nervous System Drugs Market
13.7.7.1. Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.8. New Zealand Central Nervous System Drugs Market
13.7.8.1. New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.9. Philippines Central Nervous System Drugs Market
13.7.9.1. Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.10. Singapore Central Nervous System Drugs Market
13.7.10.1. Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.11. South Korea Central Nervous System Drugs Market
13.7.11.1. South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.11.2. South Korea Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.12. Thailand Central Nervous System Drugs Market
13.7.12.1. Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
13.7.13. Vietnam Central Nervous System Drugs Market
13.7.13.1. Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Central Nervous System Drugs Market
14.1. Western Europe Central Nervous System Drugs Market Overview
14.2. Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
14.3. Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
14.4. Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
14.5. Western Europe, Central Nervous System Drugs Market Metrics
14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
14.6. Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7. Western Europe Central Nervous System Drugs Market: Country Analysis
14.7.1. Austria Central Nervous System Drugs Market
14.7.1.1. Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.2. Belgium Central Nervous System Drugs Market
14.7.2.1. Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.3. Denmark Central Nervous System Drugs Market
14.7.3.1. Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.4. Finland Central Nervous System Drugs Market
14.7.4.1. Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.5. France Central Nervous System Drugs Market
14.7.5.1. France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.5.2. France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.6. Germany Central Nervous System Drugs Market
14.7.6.1. Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.6.2. Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.7. Ireland Central Nervous System Drugs Market
14.7.7.1. Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.8. Italy Central Nervous System Drugs Market
14.7.8.1. Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.9. Netherlands Central Nervous System Drugs Market
14.7.9.1. Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.10. Norway Central Nervous System Drugs Market
14.7.10.1. Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.11. Portugal Central Nervous System Drugs Market
14.7.11.1. Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.12. Spain Central Nervous System Drugs Market
14.7.12.1. Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.13. Sweden Central Nervous System Drugs Market
14.7.13.1. Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.14. Switzerland Central Nervous System Drugs Market
14.7.14.1. Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.15. UK Central Nervous System Drugs Market
14.7.15.1. UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
14.7.15.2. UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Central Nervous System Drugs Market
15.1. Eastern Europe Central Nervous System Drugs Market Overview
15.2. Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
15.3. Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
15.4. Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
15.5. Eastern Europe, Central Nervous System Drugs Market Metrics
15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
15.6. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
15.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
15.7.1. Czech Republic Central Nervous System Drugs Market,
15.7.1.1. Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
15.7.2. Poland Central Nervous System Drugs Market
15.7.2.1. Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
15.7.3. Romania Central Nervous System Drugs Market
15.7.3.1. Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
15.7.4. Russia Central Nervous System Drugs Market
15.7.4.1. Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
15.7.4.2. Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Central Nervous System Drugs Market
16.1. North America Central Nervous System Drugs Market Overview
16.2. North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
16.3. North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
16.4. North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
16.5. North America, Central Nervous System Drugs Market Metrics
16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
16.6. North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
16.7. North America Central Nervous System Drugs Market: Country Analysis
16.7.1. Canada Central Nervous System Drugs Market
16.7.1.1. Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
16.7.2. Mexico Central Nervous System Drugs Market
16.7.2.1. Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
16.7.3. USA Central Nervous System Drugs Market
16.7.3.1. USA Central Nervous System Drugs Market Overview
16.7.3.2. USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
16.7.3.3. USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Central Nervous System Drugs Market
17.1. South America Central Nervous System Drugs Market Overview
17.2. South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
17.3. South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
17.4. South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
17.5. South America, Central Nervous System Drugs Market Metrics
17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
17.6. South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7. South America Central Nervous System Drugs Market: Country Analysis
17.7.1. Argentina Central Nervous System Drugs Market
17.7.1.1. Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.2. Brazil Central Nervous System Drugs Market
17.7.1.1. Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.2.2. Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.3. Chile Central Nervous System Drugs Market
17.7.3.1. Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.4. Colombia Central Nervous System Drugs Market
17.7.4.1. Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.5. Peru Central Nervous System Drugs Market
17.7.5.1. Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
17.7.6. Venezuela Central Nervous System Drugs Market
17.7.6.1. Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Central Nervous System Drugs Market
18.1. Middle East Central Nervous System Drugs Market Overview
18.2. Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
18.3. Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
18.4. Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
18.5. Middle East, Central Nervous System Drugs Market Metrics
18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
18.6. Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
18.7. Middle East Central Nervous System Drugs Market: Country Analysis
18.7.1. Saudi Arabia Central Nervous System Drugs Market
18.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
18.7.2. Israel Central Nervous System Drugs Market
18.7.2.1. Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
18.7.3. Turkey Central Nervous System Drugs Market
18.7.3.1. Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
18.7.4. UAE Central Nervous System Drugs Market
18.7.4.1. UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Central Nervous System Drugs Market
19.1. Africa Central Nervous System Drugs Market Overview
19.2. Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
19.3. Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
19.4. Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
19.5. Africa, Central Nervous System Drugs Market Metrics
19.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
19.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
19.6. Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
19.7. Africa Central Nervous System Drugs Market: Country Analysis
19.7.1. Egypt Central Nervous System Drugs Market
19.7.1.1. Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
19.7.2. Nigeria Central Nervous System Drugs Market
19.7.2.1. Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
19.7.3. South Africa Central Nervous System Drugs Market
19.7.3.1. South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Central Nervous System Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Biogen Inc
20.3.1.1. Company Overview
20.3.1.2. Products And Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Johnson & Johnson
20.3.2.1. Company Overview
20.3.2.2. Products And Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Novartis AG
20.3.3.1. Company Overview
20.3.3.2. Products And Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. UCB S.A.
20.3.4.1. Company Overview
20.3.4.2. Products And Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Takeda Pharmaceuticals
20.3.5.1. Company Overview
20.3.5.2. Products And Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

22. Market Background: Pharmaceutical Drugs Market
22.1. Pharmaceutical Drugs Market Characteristics
22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global
22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations
23.1. Global Central Nervous System Drugs Market In 2026- Growth Countries
23.2. Global Central Nervous System Drugs Market In 2026- Growth Segments
23.3. Global Central Nervous System Drugs Market In 2026- Growth Strategies

24. Appendix
24.1. NAICS Definitions Of Industry Covered In This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company

25. Copyright And Disclaimer

List of Tables
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
Table 4: Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Central Nervous System Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
Table 13: Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
Table 14: Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 15: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 16: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 17: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
Table 18: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
Table 19: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 20: China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 21: China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 22: Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 23: Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 24: Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 25: India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 26: India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 27: Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 28: Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 29: Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 30: Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 31: Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 32: New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 33: Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 34: Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 35: South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 36: Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 37: Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 38: Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 39: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 40: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 41: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
Table 42: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
Table 43: Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 44: Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 45: Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 46: Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 47: Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 48: France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 49: France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 50: Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 51: Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 52: Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 53: Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 54: Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 55: Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 56: Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 57: Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 58: Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 59: Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 60: UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 61: UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 62: Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 63: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 64: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 65: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
Table 66: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
Table 67: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 68: Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 69: Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 70: Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 71: Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 72: Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 73: North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 74: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 75: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 76: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
Table 77: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
Table 78: North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 79: Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 80: Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 81: USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 82: USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 83: South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 84: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 85: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 86: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
Table 87: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
Table 88: South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 89: Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 90: Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 91: Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 92: Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 93: Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 94: Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 95: Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 96: Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 97: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 98: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 99: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
Table 100: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
Table 101: Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 102: Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 103: Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 104: Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 105: UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 106: Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Table 107: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Table 108: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Table 109: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
Table 110: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
Table 111: Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 112: Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 113: Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 114: South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Table 115: Biogen Inc Financial Performance
Table 116: Johnson & Johnson Financial Performance
Table 117: Novartis AG Financial Performance
Table 118: UCB S.A. Financial Performance
Table 119: Takeda Pharmaceuticals Financial Performance
Table 120: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
Table 121: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
Table 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
Table 123: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
Table 124: Global Central Nervous System Drugs Market In 2026- Growth Countries
Table 125: Global Central Nervous System Drugs Market In 2026- Growth Segments
Table 126: Global Central Nervous System Drugs Market In 2026- Growth Strategies

List of Figures
Figure 1: Historic Market Growth, Value ($ Billion)
Figure 2: Forecast Market Growth, Value ($ Billion)
Figure 3: Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
Figure 4: Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Central Nervous System Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
Figure 13: Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
Figure 14: Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 15: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 16: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 17: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
Figure 18: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
Figure 19: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 20: China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 21: China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 22: Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 23: Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 24: Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 25: India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 26: India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 27: Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 28: Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 29: Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 30: Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 31: Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 32: New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 33: Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 34: Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 35: South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 36: Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 37: Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 38: Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 39: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 40: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 41: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
Figure 42: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
Figure 43: Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 44: Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 45: Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 46: Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 47: Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 48: France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 49: France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 50: Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 51: Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 52: Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 53: Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 54: Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 55: Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 56: Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 57: Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 58: Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 59: Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 60: UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 61: UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 62: Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 63: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 64: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 65: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
Figure 66: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
Figure 67: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 68: Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 69: Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 70: Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 71: Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 72: Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 73: North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 74: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 75: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 76: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
Figure 77: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
Figure 78: North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 79: Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 80: Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 81: USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 82: USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 83: South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 84: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 85: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 86: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
Figure 87: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
Figure 88: South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 89: Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 90: Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 91: Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 92: Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 93: Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 94: Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 95: Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 96: Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 97: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 98: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 99: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
Figure 100: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
Figure 101: Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 102: Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 103: Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 104: Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 105: UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 106: Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
Figure 107: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
Figure 108: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
Figure 109: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
Figure 110: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
Figure 111: Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 112: Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 113: Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 114: South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
Figure 115: Biogen Inc Financial Performance
Figure 116: Johnson & Johnson Financial Performance
Figure 117: Novartis AG Financial Performance
Figure 118: UCB S.A. Financial Performance
Figure 119: Takeda Pharmaceuticals Financial Performance
Figure 120: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
Figure 121: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
Figure 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
Figure 123: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
Figure 124: Global Central Nervous System Drugs Market In 2026- Growth Countries
Figure 125: Global Central Nervous System Drugs Market In 2026- Growth Segments
Figure 126: Global Central Nervous System Drugs Market In 2026- Growth Strategies